Tag Archive for: HAVN Life Sciences
Math Over Myth: Psychedelic Stock HAVN Life Collapses
Business, Stock ReportsThe psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow
Psychedelic Business Spotlight: August 27, 2021
Business, Stock ReportsDelic establishes medical board to oversee psychedelic treatment protocols, cool new delivery systems investigated for psychedelics, and VR meets psychedelic therapies, finally.
Psychedelic Business Spotlight: July 30, 2021
Business, Stock ReportsThis week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.
Psychedelic Companies HAVN Life Sciences, MINDCURE Health Reach Manufacturing Milestones
BusinessThe global supply chain of regulated psilocybin and ibogaine continues to grow as these Canadian companies beef up manufacturing efforts.